What Is the Prognosis of an Acute Myocardial Infarction in the Presence of Moderate Aortic Stenosis?

Aortic stenosis (AS) is a common condition that shares risk factors with coronary artery disease. Many patients can suffer from both diseases simultaneously, something that increases the risk of acute myocardial infarction in the presence of aortic stenosis.

¿Cuál es el pronóstico de un infarto agudo de miocardio en presencia de estenosis aórtica moderada?

AS can cause ischemia even in the absence of coronary artery disease, due to ventricular hypertrophy, increased ventricular loads, and microcirculation disorders.

The presence of moderate AS in acute coronary syndrome can influence its clinical course. While there are several published works on this topic, the best strategy to follow is still unclear, as current guidelines do not provide specific recommendations in this regard.

A retrospective analysis was conducted on 1373 patients who experienced acute coronary syndrome, with or without ST-segment elevation, between 2005 and 2016. Of these, 183 patients (13.3%) had moderate aortic stenosis, while the remaining 1190 either did not have it or had mild stenosis.

Patients with moderate AS were older and had a higher prevalence of comorbidities such as diabetes, hypertension, dyslipidemia, myocardial infarction, myocardial revascularization surgery (MRS), stroke, impaired renal function, and a lower left ventricular ejection fraction (48.3 ± 13.5 vs. 51.4 ± 12.3, p = 0.006).

Read also: Is Edge-to-Edge Treatment with PASCAL Effective at 3 Years?

There were no differences in terms of access used, but the number of diseased vessels and the number of stents used were higher in patients with moderate aortic stenosis.

During hospitalization, there were no differences in terms of mortality or cardiogenic shock between the groups, but the heart failure rate was higher in patients with moderate aortic stenosis compared to those without stenosis or with mild stenosis.

At the one-year follow-up, mortality was higher in the group with moderate aortic stenosis (23.9% vs. 8.1%, p < 0.001), and so were hospitalizations for heart failure (8.3% vs. 3.7%, p = 0.028).

During hospitalizations for heart failure, mortality was higher for patients with moderate aortic stenosis both in-hospital and at one year, but there were no differences in those with mild aortic stenosis or without stenosis.

Read also: Relationship between Distal Vessel Quality and Outcomes in the Treatment of Chronic Total Occlusions.

In a multivariate analysis, the presence of moderate aortic stenosis was associated with a 2.4-fold increase in mortality in patients with acute coronary syndrome, whether with or without ST-segment elevation and moderate aortic stenosis.

Conclusion

The presence of moderate aortic stenosis in patients with acute myocardial infarction was associated with an unfavorable clinical course during hospitalization and at a one-year follow-up. These findings highlight the importance of close monitoring of these patients and determining the best treatment strategy based on existing conditions.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study.

Reference: Abraham, et al.Catheter Cardiovasc Interv. 2023;102:159–165.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...